By Eli McVey The number of medical marijuana patients in Canada skyrocketed in recent months, and patterns of consumption are evolving as the market grows. The latest data from Health Canada shows patient counts in the country have reached nearly 300,000, up from 175,000 in April 2017 – a 70% increase. Further data from the government – which includes detailed records of MMJ sales from licensed producers to patients – reveals two key findings: While individual usage can vary greatly, these results point to broad trends playing out in the market. Declining per-patient consumption indicates that patient growth is increasing at a faster rate than sales of dry cannabis and cannabis oil, likely driven by newer patients joining the MMJ program and treating less chronic or severe conditions that require lower doses of THC. These new patients appear to show a preference for cannabis oil, boosting average daily per-patient consumption of oil as they enter the market. Though flower consumption is on the decline, limitations on potency and product choice for cannabis oils – combined with higher prices – have kept the use of flower as the primary method of ingestion for most MMJ patients. Chart: Consumption habits changing in Canada’s booming medical marijuana market

thumbnail courtesy of